IQ Research Journal-Open Access-ISSN:2790-4296

Prevalence Of Elevated Serum Prostate Specific Antigen Among Males 40 Years And Above Attending The Bamenda Regional Hospital

PAPER DETAILS

CITE THIS

Authors Name Tumi Humphred S, Enow.A J, Nzibobi.D. N Paper Prevalence Of Elevated Serum Prostate Specific Antigen AmongĀ Males 40 Years And Above Attending The Bamenda Regional Hospital

IQ Research Journal of IQ res. j. (2022)1(1): pp 01-17. Vol. 001, Issue 001, 01-2022, pp. 075-092
Received: 01 12, 2021; Accepted: 20 01, 2022; Published: 27 01, 2022

ABSTRACT

Background: Recent report in Cameroon shows a high incidence of prostate cancer. This study set out to investigate the prevalence of elevated prostate specific antigen among men 40 years and above attending the Bamenda Regional Hospital of the Northwest Region of Cameroon. Men screened for serum prostate specific antigen (PSA) and those with PSA values greater than 4ng/ml were considered suspicious for prostate cancer. Methods: A total of 147 Men of age 40 years and above were considered appropriately suitable for this research work, after due consultation with each participant, a
questionnaire form was given to each of the subjects to fill which help in categorizing the patients into their age groups, patients whose age were below age studied group (40 years and above) were restricted from participating in the study. Blood samples were collected from the subjects into plane bottles, spun at 3,000 rpm (revolution per minutes), serum was separated and then analyze with a spectrophotometer at 450 nm. Results: It was observed that about 73.0% of the study subjects, had protein specific antigen values within the normal range and about 25% of the subjects are at risk and
about 20.0% of the subjects has prostatic cancer with values above 10 ng/ml. Conclusion: Base on the assessment of protein specific antigen in men attending the Bamenda regional Hospital, the prevalence of the disease prostate cancer among elderly men is relatively high (hyperplasia).

RELATED PAPERS